MedTrace Logo

Study of Early Hormone Replacement Therapy on Risk Factors for Sudden Cardiac Death

NCT00580775 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2015-01-22

No results posted yet for this study

Summary

As an ancillary study to the KEEPS study (see ClinicalTrials.gov Identifier: NCT00154180), the primary purpose is to measure effects of estrogen vs. placebo in menopausal women, on autonomic function and repolarization; both measured non-invasively via holter monitoring.

Conditions

  • Menopausal Women

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Rachel Lampert, M.D. · Yale University

Eligibility

Min Age
42 Years
Max Age
58 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2008-07-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00580775 on ClinicalTrials.gov